e-learning
resources
Vienna 2012
Monday, 03.09.2012
New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Circulating collagen indices indicative of disease severity in pulmonary arterial hypertension
Z. Safdar (Houston, United States Of America)
Source:
Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Session:
New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Session type:
Thematic Poster Session
Number:
2735
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Safdar (Houston, United States Of America). LATE-BREAKING ABSTRACT: Circulating collagen indices indicative of disease severity in pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 2735
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Circulating collagen biomarker and quality of life in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 210-212
Year: 2012
Circulating fibrocytes in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2011; 39: 210-212
Year: 2012
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
Source: Eur Respir Rev 2014; 23: 505-509
Year: 2014
Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Increased arterial stiffness in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 65s
Year: 2006
C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
Low T3-syndrome and respiratory muscle dysfunction in patients with pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 545s
Year: 2006
Determinants and prognostic value of kidney disease in pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Assessment of the BODE index, arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012
Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept